Five Key Measures to Ensure a Quality ColonoscopySeptember 10, 2024Colorectal CancerOncologyColon and Rectal
“It Takes a Village”: Benefits and Challenges of Navigating Cancer Care with the Pacific Community and the Veterans Health AdministrationSeptember 10, 2024OncologyCancer
Influence of Patient Demographics and Facility Type on Overall Survival in Sezary SyndromeSeptember 10, 2024Oncology
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple MyelomaSeptember 10, 2024OncologyMultiple MyelomaHematologic Malignancies
Male Patient With a History of Monoclonal B Cell Lymphocytosis Presenting with Breast Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report and Literature ReviewSeptember 10, 2024Oncology
Chronic Myeloid Leukemia Presenting as Priapism: A Rare and Acute Initial Presentation in a Young MaleSeptember 9, 2024OncologyHematologic Malignancies
Agent Orange and Myelodysplastic Syndrome: A Single VAMC ExperienceSeptember 9, 2024OncologyMyelodysplastic Syndrome
The First Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors T-cell Therapy for Refractory Multiple Myeloma and the Role of Intravenous Immunoglobulin in the Prevention of Therapy-associated InfectionsSeptember 9, 2024OncologyMultiple Myeloma
The First Female Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors (CAR) T-cell Therapy for Refractory Multiple Myeloma and the Role of CAR T-cell Therapy in Penta-refractory DiseaseSeptember 9, 2024OncologyMultiple MyelomaHematologic Malignancies
A Clonal Complete Remission Induced by IDH1 Inhibitor Ivosidenib in a Myelodysplastic Syndrome (MDS) With Co-Mutations of IDH1 and the ZRSR2 RNA Splicing GeneSeptember 9, 2024OncologyMyelodysplastic Syndrome
Treatment Patterns and Outcomes of Older (Age ≥ 80) Veterans With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)September 9, 2024OncologyCancer
